Brazil: Anvisa banned the marketing and advertising of the dietary supplements Lipotramine and Lipozepine, illegally sold as weight loss products

The National Health Surveillance Agency (ANVISA in Portuguese) banned the marketing, distribution, manufacture and advertising of the dietary supplements Lipotramine and Lipozepine, illegally sold as weight loss products, mainly on the internet, and determined their withdrawal. The measure was published by Resolution (RE) No. 2,167, dated June 30, 2022. The products are manufactured by Guki Nutracêutica Ltda. (CNPJ: 06789363000134).

Foods may not bear therapeutic claims

Anvisa has not approved weight loss claims for food supplements. Thus, any advertising that conveys such claims is irregular.